Are you Dr. Cook?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 45 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1330 Rockefeller Ave
Ste 520
Everett, WA 98201Phone+1 425-267-5200- Is this information wrong?
Summary
- Dr. James Cook Jr., MD is a vascular surgeon in Everett, Washington. He is currently licensed to practice medicine in Washington, Utah, and Texas. He is affiliated with Providence Regional Medical Center Everett, EvergreenHealth Monroe, and Providence Swedish Edmonds.
Education & Training
University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Vascular Surgery, 1989 - 1991
University of Utah HealthResidency, Surgery, 1981 - 1987
University of Texas Southwestern Medical SchoolClass of 1981
Certifications & Licensure
WA State Medical License 1991 - 2025
UT State Medical License 1982 - 1988
TX State Medical License 1981 - 1987
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 4 citationsPositive modulation of α5GABAA receptors leads to dichotomous effects in rats on memory pattern and GABRA5 expression in prefrontal cortex and hippocampus.Anja Santrač, Bojan Batinić, Tamara Timic Stamenic, Jovana Aranđelović, Dishary Sharmin, Daniel E. Knutson, James M. Cook, Miroslav M. Savić> ;Behavioural Brain Research. 2022 Jan 7
- 2 citationsIdentification and Quantification of MIDD0301 metabolites.M S Rashid Roni, Nicolas M Zahn, Brandon N Mikulsky, Daniel A. Webb, Yeunus Mian, Daniel E. Knutson, Margaret L. Guthrie, James M. Cook, Douglas C. Stafford, Leggy A. ...> ;Current Drug Metabolism. 2021 Dec 1
- 45 citationsGABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors.Rok Cerne, Arnold S. Lippa, Michael M. Poe, Jodi L. Smith, Xiaoming Jin, Xingjie Ping, Lalit K. Golani, James M. Cook, Jeffrey M. Witkin> ;Pharmacology & Therapeutics. 2021 Nov 16
- Join now to see all
Grant Support
- Targeting System Xc- For The Treatment Of AddictionNational Institute On Drug Abuse2009–2010
- Design And Synthesis Of Anxioselective AnxiolyticsNational Institute Of Mental Health2006–2010
- Development Of Compounds Targeting Xc- For The Treatment Of SchizophreniaNational Institute Of Mental Health2008–2009
- Flow Cytometry FacilityNational Cancer Institute2005–2009
- Selective Anxiolytics VIA Bzr Subtype Specific LigandsNational Institute Of Mental Health1997–2005
- Rigid Probes--Modeling Selective Anxiolytics For BzrNational Institute Of Mental Health1994–1995
- Rigid Probes: Modeling Selective Anxiolytics For BzrNational Institute Of Mental Health1991–1993
- Beta-Carbolines: Valium Agonists And AntagonistsNational Institute Of Mental Health1988–1992
- Characterization Of BZ Receptors &Punished RespondingNational Institute On Drug Abuse1988
- Analytical High Pressure Liquid ChromatographyNational Institute Of Environmental Health Sciences1988
- Stereospecific Approach To Macroline-Related AlkaloidsNational Institute Of Neurological Disorders And Stroke1986–1988
- B-Carbolines: Search For Valium Agonists &AntagonistsNational Institute Of Mental Health1985–1987
Professional Memberships
- Member
- Member
Hospital Affiliations
EvergreenHealthKirkland, Washington- Olympic Medical CenterPort Angeles, Washington
Providence Regional Medical Center EverettEverett, Washington- Providence Swedish EdmondsEdmonds, Washington
Swedish Cherry Hill CampusSeattle, Washington- EvergreenHealth MonroeMonroe, Washington
- WhidbeyHealthCoupeville, Washington
